Collectively, our findings position Erk1/2 as a nodal regulator orchestrating the tripartite interplay between ferroptosis susceptibility, Nrf1/2‐mediated redox adaptation and mitochondrial plasticity in HCC. The gene discussed is MAPK3; the disease is hepatocellular carcinoma.